Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype-phenotype associations in Rett syndrome

被引:49
作者
Charman, T
Neilson, TC
Mash, V
Archer, H
Gardiner, MT
Knudsen, GPS
McDonnell, A
Perry, J
Whatley, SD
Bunyan, DJ
Ravn, K
Mount, RH
Hastings, RP
Hulten, M
Orstavik, KH
Reilly, S
Cass, H
Clarke, A
Kerr, AM
Bailey, MES
机构
[1] UCL, Inst Child Hlth, Behav & Brain Sci Unit, London WC1N 1EH, England
[2] Univ Glasgow, Div Mol Genet, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland
[3] Cardiff Univ, Coll Med, Dept Med Genet, Cardiff, Wales
[4] Univ Oslo, Rikshosp, Fac Div, N-0027 Oslo, Norway
[5] Univ Wales Hosp, Dept Med Biochem & Immunol, Cardiff, Wales
[6] Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England
[7] Univ Copenhagen Hosp, Rikshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark
[8] Univ Wales, Sch Psychol, Bangor, Gwynedd, Wales
[9] Univ Warwick, Dept Biol Sci, Warwick, England
[10] Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway
[11] La Trobe Univ, Sch Human Commun Sci, Melbourne, Vic, Australia
[12] Univ Glasgow, Dept Med Psychol, Glasgow, Lanark, Scotland
基金
英国经济与社会研究理事会;
关键词
Rett syndrome; MECP2; mutation; phenotype; association;
D O I
10.1038/sj.ejhg.5201471
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We aimed to improve the understanding of genotype-phenotype correlations in Rett syndrome (RS) by adopting a novel approach to categorising phenotypic dimensions - separating typicality of presentation, outcome severity and age of onset - and by classifying MECP2 mutations strictly by predicted functional attributes. MECP2 mutation screening results were available on 190 patients with a clinical diagnosis of RS (140 cases with classic RS, 50 with atypical RS). 135 cases had identified mutations. Of the 140 patients, 116 with classic RS (82.9%) had an identified mutation compared with 19 of 50 patients (38%) with an atypical presentation. Cases with early onset of regression and seizures, and those with clinical features that might indicate alternative aetiologies, were less likely to have mutations. Individuals with late truncating mutations had a less typical presentation than cases with missense and early truncating mutations, presumably reflecting greater residual function of MECP2 protein. Individuals with early truncating mutations had a more severe outcome than cases with missense and late truncating mutations. These findings held when restricting the analysis to cases over 15 years of age and classic cases only. Previous findings of variation in severity among the common mutations were confirmed. The approach to phenotypic and genotypic classification adopted here allowed us to identify genotype-phenotype associations in RS that may aid our understanding of pathogenesis and also contribute to clinical knowledge on the impact of different types of mutations.
引用
收藏
页码:1121 / 1130
页数:10
相关论文
共 34 条
  • [1] Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
    Amir, RE
    Van den Veyver, IB
    Wan, M
    Tran, CQ
    Francke, U
    Zoghbi, HY
    [J]. NATURE GENETICS, 1999, 23 (02) : 185 - 188
  • [2] X-chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain
    Braunschweig, D
    Simcox, T
    Samaco, RC
    LaSalle, JM
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (12) : 1275 - 1286
  • [3] Findings from a multidisciplinary clinical case series of females with Rett syndrome
    Cass, H
    Reilly, S
    Owen, L
    Wisbeach, A
    Weekes, L
    Slonims, V
    Wigram, T
    Charman, T
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2003, 45 (05) : 325 - 337
  • [4] Long-read sequence analysis of the MECP2 gene in Rett syndrome patients:: correlation of disease severity with mutation type and location
    Cheadle, JP
    Gill, H
    Fleming, N
    Maynard, J
    Kerr, A
    Leonard, H
    Krawczak, M
    Cooper, DN
    Lynch, S
    Thomas, N
    Hughes, H
    Hulten, M
    Ravine, D
    Sampson, JR
    Clarke, A
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (07) : 1119 - 1129
  • [5] MECP2 and beyond:: Phenotype-genotype correlations in Rett syndrome
    Christodoulou, J
    Weaving, LS
    [J]. JOURNAL OF CHILD NEUROLOGY, 2003, 18 (10) : 669 - 674
  • [6] Refining the phenotype of common mutations in Rett syndrome
    Colvin, L
    Leonard, H
    de Klerk, N
    Davis, M
    Weaving, L
    Williamson, S
    Christodoulou, J
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (01) : 25 - 30
  • [7] Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients
    Erlandson, A
    Samuelsson, L
    Hagberg, B
    Kyllerman, M
    Vujic, M
    Wahlström, J
    [J]. GENETIC TESTING, 2003, 7 (04): : 329 - 332
  • [8] Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls
    Evans, JC
    Archer, HL
    Whatley, SD
    Kerr, A
    Clarke, A
    Butler, R
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (01) : 124 - 126
  • [9] Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P12
  • [10] CLINICAL DELINEATION OF RETT-SYNDROME VARIANTS
    HAGBERG, B
    [J]. NEUROPEDIATRICS, 1995, 26 (02) : 62 - 62